Prevalence of Androgen Receptor Expression in Triple Negative Breast Cancers According To BRCA1 Mutation Status

被引：0
|
作者：
Torous, Vanda Farahmand
Schnitt, Stuart
Garber, Judy
Hacker, Michele
Poles, Emily
Alexander, Brian
Lee, Larissa
Collins, Laura
Tung, Nadine
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
164
引用
收藏
页码：44A / 44A
页数：1
相关论文
共 50 条
  • [31] Ubc9 Expression in Correlation with BRCA1 in Hormone Positive (HP) and Triple Negative Breast Cancers
    du Jour, Kimberly Point
    Agboola, A. O. J.
    Green, Andrew
    Liu, Yuan
    Ellis, Ian
    Rao, Veena N.
    Oprea-Ilies, Gabriela
    MODERN PATHOLOGY, 2017, 30 : 66A - 66A
  • [32] Racial differences in Androgen Receptor status among triple-negative breast cancers
    Shristi, Bhattarai
    Xia, Jun
    Wetherilt, Ceyda Sonmez
    Klimov, Sergey
    Riaz, Ansa
    Pattni, Sonal
    Aleskandarany, Mohammad A.
    Green, Andrew R.
    Rakha, Emad A.
    Ellis, Ian O.
    Cantuaria, Guilherme
    Li, Xiaoxian
    Krishnamurthi, Uma
    Osan, Remus Mihai
    Rida, Padmashree C. G.
    Aneja, Ritu
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (02)
  • [33] Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Tung, Nadine
    Miron, Alexander
    Schnitt, Stuart J.
    Gautam, Shiva
    Fetten, Katharina
    Kaplan, Jennifer
    Yassin, Yosuf
    Buraimoh, Ayodele
    Kim, Ji-Young
    Szasz, Attila M.
    Tian, Ruiyang
    Wang, Zhigang C.
    Collins, Laura C.
    Brock, Jane
    Krag, Karen
    Legare, Robert D.
    Sgroi, Dennis
    Ryan, Paula D.
    Silver, Daniel P.
    Garber, Judy E.
    Richardson, Andrea L.
    BREAST CANCER RESEARCH, 2010, 12 (06)
  • [34] Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Nadine Tung
    Alexander Miron
    Stuart J Schnitt
    Shiva Gautam
    Katharina Fetten
    Jennifer Kaplan
    Yosuf Yassin
    Ayodele Buraimoh
    Ji-Young Kim
    Attila M Szász
    Ruiyang Tian
    Zhigang C Wang
    Laura C Collins
    Jane Brock
    Karen Krag
    Robert D Legare
    Dennis Sgroi
    Paula D Ryan
    Daniel P Silver
    Judy E Garber
    Andrea L Richardson
    Breast Cancer Research, 12
  • [35] Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
    Nakamura, Kivvi Duarte
    Ferreira, Elisa
    Ramalho, Rodrigo
    Brianese, Rafael
    Carraro, Dirce
    CANCER RESEARCH, 2017, 77
  • [36] BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAness
    Domagala, Pawel
    Hybiak, Jolanta
    Cybulski, Cezary
    Lubinski, Jan
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (07) : 1545 - 1550
  • [37] Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer
    Maksimenko, Jelena
    Irmejs, Arvids
    Nakazawa-Miklasevica, Miki
    Melbarde-Gorkusa, Inga
    Trofimovics, Genadijs
    Gardovskis, Janis
    Miklasevics, Edvins
    ONCOLOGY LETTERS, 2014, 7 (01) : 278 - 284
  • [38] BRCA1 mutation is strongly associated with a triple negative phenotype in breast cancer patients
    Cordoba, O.
    Rubio, I.
    Xercavins, J.
    Diez, O.
    Alvarez, M.
    Cortadellas, T.
    Balmana, J.
    EJC SUPPLEMENTS, 2010, 8 (03): : 108 - 108
  • [39] Clinical Outcome of Triple Negative Breast Cancer in BRCA1 Mutation Carriers and Noncarriers
    Lee, Larissa J.
    Alexander, Brian
    Schnitt, Stuart J.
    Comander, Amy
    Gallagher, Bridget
    Garber, Judy E.
    Tung, Nadine
    CANCER, 2011, 117 (14) : 3093 - 3100
  • [40] Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer
    Danzinger, Sabine
    Tan, Yen Yen
    Rudas, Margaretha
    Kastner, Marie-Theres
    Weingartshofer, Sigrid
    Muhr, Daniela
    Singer, Christian F.
    CANCER INVESTIGATION, 2018, 36 (07) : 378 - 388
12345